Long-term health consequences of premature or early menopause and considerations for management

Climacteric

Volumn 18, Issue 4, 2015, Pages 483-491

  Faubion, S S ^a   Kuhle, C L ^a   Shuster, L T ^a   Rocca, W A ^a  

^a MAYO CLINIC   (United States)

Author keywords

early menopause; estrogen; hormone therapy; oophorectomy; Premature menopause

Indexed keywords

ESTROGEN;

ADULT; AGED; BONE; BONE DENSITY; CARDIOVASCULAR EFFECT; COGNITION; CONTRACEPTION; EARLY MENOPAUSE; ESTROGEN DEFICIENCY; FEMALE; FERTILITY; HEALTH; HORMONAL THERAPY; HUMAN; MEDICAL SOCIETY; MOOD; MORTALITY; OVARY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; RISK; SALPINGOOOPHORECTOMY; SEXUAL FUNCTION; SEXUAL HEALTH; ADVERSE EFFECTS; DRUG EFFECTS; ESTROGEN THERAPY; MENTAL HEALTH; OVARIECTOMY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; PSYCHOLOGY; SALPINGECTOMY;

ADULT; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE, PREMATURE; MENTAL HEALTH; OVARIECTOMY; POSTOPERATIVE COMPLICATIONS; PRIMARY OVARIAN INSUFFICIENCY; SALPINGECTOMY;

EID: 84932093564     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2015.1020484     Document Type: Review

References (99)

1. Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008; 14: 111-16
2. Rocca W A, Ulrich L G. O ophorectomy for whom and at what age? Primum non nocere. Maturitas 2012; 71: 1-2
3. Parker W H, Feskanich D, Broder M S, et al. L ong-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses ' Health Study. Obstet Gynecol 2013; 121: 709-16
4. Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ. Elective oophorectomy in the United States: Trends and in-hospital complications, 1998-2006. Obstet Gynecol 2010; 116: 1088-95
5. Harmanli O, Shinnick J, Jones K, St Marie P. Obstetriciangynecologists ' opinions on elective bilateral oophorectomy at the time of hysterectomy in the United States: A nationwide survey. Menopause 2014; 21: 355-60
6. Llaneza P, Perez-Lopez FR. Rethinking elective bilateral oophorectomy at the time of hysterectomy for benign disease. Maturitas 2013; 76: 109-10
7. Miro F, Parker S W, Aspinall L J, Coley J, Perry P W, Ellis J E. Sequential classification of endocrine stages during reproductive aging in women: The FREEDOM study. Menopause 2005; 12: 281-90
8. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992; 14: 103-15
9. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18: 199-206
10. Cox L, Liu JH. Primary ovarian insufficiency: An update. Int J Women's Health 2014; 6: 235-43
11. Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006; 26: 10332-48
12. Rocca W A, Grossardt B R, Shuster L T. O ophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011; 1379: 188-98
13. Rocca W A, Shuster L T, Grossardt B R, et al. L ong-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) 2009; 5: 39-48
14. Rocca W A, Bower J H, Maraganore D M, et al. I ncreased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007; 69: 1074-83
15. Phung T K, Waltoft B L, Laursen T M, et al. H ysterectomy, oophorectomy and risk of dementia: A nationwide historical cohort study. Dement Geriatr Cogn Disord 2010; 30: 43-50
16. Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 2014; 82: 222-9
17. Rocca WA, Henderson VW. Is there a link between gynecologic surgeries and Alzheimer disease? Neurology 2014; 82: 196-7
18. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007; 356: 2639-41
19. Rocca W A, Grossardt B R, Shuster L T. O ophorectomy, estrogen, and dementia: A 2014 update. Mol Cell Endocrinol 2014; 389: 7-12
20. Shumaker S A, Legault C, Kuller L, et al. C onjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-58
21. Henderson V W, Benke K S, Green R C, Cupples L A, Farrer L A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neuro Psychiatry 2005; 76: 103-5
22. Shao H, Breitner JC, Whitmer RA, et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012; 79: 1846-52
23. Whitmer R A, Quesenberry C P, Zhou J, Yaffe K. T iming of hormone therapy and dementia: The critical window theory revisited. Ann Nneurol 2011; 69: 163-9
24. Rocca W A, Bower J H, Maraganore D M, et al. I ncreased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008; 70: 200-9
25. Vajaranant T S, Grossardt B R, Maki P M, et al. R isk of glaucoma after early bilateral oophorectomy. Menopause 2014; 21: 391-8
26. Vajaranant TS, Pasquale LR. Estrogen deficiency accelerates aging of the optic nerve. Menopause 2012; 19: 942-7
27. Vingerling J R, Dielemans I, Witteman J C, Hofman A, Grobbee D E, de Jong PT. Macular degeneration and early menopause: A case-control study. BMJ 1995; 310: 1570-1
28. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14: 283-93
29. Farquhar CM, Harvey SA, Yu Y, Sadler L, Stewart AW. A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol 2006; 194: 711-17
30. KjerulffK H, Langenberg P W, Rhodes J C, Harvey L A, Guzinski GM, Stolley PD. Effectiveness of hysterectomy. Obstet Gynecol 2000; 95: 319-26
31. Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008; 15: 1050-9
32. Gibson CJ, Joffe H, Bromberger JT, et al. Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstet Gynecol 2012; 119: 935-41
33. Benshushan A, Rojansky N, Chaviv M, et a l. C limacteric symptoms in women undergoing risk-reducing bilateral salpingooophorectomy. Climacteric 2009; 12: 404-9
34. Sayakhot P, Vincent A, Deeks A, Teede H. Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer. Menopause 2011; 18: 786-93
35. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360: 606-14
36. Orshan SA, Furniss KK, Forst C, Santoro N. The lived experience of premature ovarian failure. J Obstet Gynecol Neonatal Nurs 2001; 30: 202-8
37. Rafique S, Sterling EW, Nelson LM. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am 2012; 39: 567-86
38. O rshan SA, Ventura JL, Covington SN, Vanderhoof VH, Troendle JF, Nelson LM. Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil Steril 2009; 92: 688-93
39. Schmidt PJ, LuffJA, Haq NA, et al. Depression in women with spontaneous 46,XX primary ovarian insufficiency. J Clin Endocrinol Metab 2011; 96: E278-87
40. Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006; 295: 1374-6
41. GroffAA, Covington SN, Halverson LR, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005; 83: 1734-41
42. Pouilles J M, Tremollieres F, Ribot C. [ Vertebral bone loss in perimenopause. Results of a 7-year longitudinal study]. Presse Med 1996; 25: 277-80
43. Recker R, Lappe J, Davies K, Heaney R. Characterization of perimenopausal bone loss: A prospective study. J Bone Miner Res 2000; 15: 1965-73
44. Yoshida T, Takahashi K, Yamatani H, Takata K, Kurachi H. Impact of surgical menopause on lipid and bone metabolism. Climacteric 2011; 14: 445-52
45. Hadjidakis DJ, Kokkinakis EP, Sfakianakis ME, Raptis SA. Bone density patterns after normal and premature menopause. Maturitas 2003; 44: 279-86
46. Francucci CM, Romagni P, Camilletti A, et al. Effect of natural early menopause on bone mineral density. Maturitas 2008; 59: 323-8
47. Vega E M, Egea M A, Mautalen C A. I nfluence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas 1994; 19: 117-24
48. van der Klift M, de Laet CE, McCloskey EV, et al. Risk factors for incident vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 2004; 19: 1172-80
49. van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003; 14: 525-30
50. Gardsell P, Johnell O, Nilsson BE. The predictive value of bone loss for fragility fractures in women: A longitudinal study over 15 years. Calcif Tissue Int 1991; 49: 90-4
51. Melton LJ 3rd, Crowson CS, Malkasian GD, O'Fallon WM. Fracture risk following bilateral oophorectomy. J Clin Epidemiol 1996; 49: 1111-15
52. Vesco K K, Marshall L M, Nelson H D, et al. S urgical menopause and nonvertebral fracture risk among older US women. Menopause 2012; 19: 510-16
53. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976; 85: 447-52
54. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: A meta-analysis. Menopause 2006; 13: 265-79
55. Parashar S, Reid K J, Spertus J A, Shaw L J, Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause 2010; 17: 938-45
56. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907-13
57. Ebong I A, Watson K E, GoffD C Jr, et al. A ge at menopause and incident heart failure: The Multi-Ethnic Study of Atherosclerosis. Menopause 2014; 21: 585-91
58. Rahman I, Akesson A, Wolk A. Relationship between age at natural menopause and risk of heart failure. Menopause 2015; 22: 12-16
59. Bertone-Johnson ER, Manson JE. Early menopause and subsequent cardiovascular disease. Menopause 2015; 22: 1-3
60. Gorodeski E Z. Is early menopause a risk factor for heart failure? Menopause 2014; 21: 558-60
61. Shuster L T, Rhodes D J, Gostout B S, Grossardt B R, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010; 65: 161-6
62. Rocca WA, Grossardt BR, d e Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: A population-based cohort study. Lancet Oncol 2006; 7: 821-8
63. Rivera C M, Grossardt B R, Rhodes D J, et al. I ncreased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16: 15-23
64. Gierach G L, Pfeiffer R M, Patel D A, et al. L ong-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause 2014; 21: 592-601
65. Jacoby V L, Grady D, Wactawski-Wende J, et al. O ophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011; 171: 760-8
66. Roeters van Lennep J E, Heida K Y, Bots M L, Hoek A. Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis. Eur J Prev Cardiol 2014 Oct 20; Epub ahead of print
67. Alonso de Lecinana M, Egido J A, Fernandez C, et al. R isk of ischemic stroke and lifetime estrogen exposure. Neurology 2007; 68: 33-8
68. Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010; 17: 506-10
69. Ingelsson E, Lundholm C, Johansson A L, Altman D. H ysterectomy and risk of cardiovascular disease: A population-based cohort study. Eur Heart J 2011; 32: 745-50
70. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: The Framingham Heart Study. Stroke 2009; 40: 1044-49
71. Parker W H, Broder M S, Chang E, et a l. O varian conservation at the time of hysterectomy and long-term health outcomes in the Nurses ' Health Study. Obstet Gynecol 2009; 113: 1027-37
72. Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown RD Jr. Premature menopause or early menopause and risk of ischemic stroke. Menopause 2012; 19: 272-7
73. Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: The Multi-Ethnic Study of Atherosclerosis. Menopause 2012; 19: 1081-7
74. Graziottin A, Basson R. S exual dysfunction in women with premature menopause. Menopause 2004; 11: 766-77
75. Graziottin A. M enopause and sexuality: key issues in premature menopause and beyond. Ann NY Acad Sci 2010; 1205: 254-61
76. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013; 20: 888-902
77. Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006; 24: 3576-82
78. Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004; 104: 1042-50
79. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 2004; 291: 47-53
80. Steinkellner AR, Denison SE, Eldridge SL, Lenzi LL, Chen W, Bowlin SJ. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative. Menopause 2012; 19: 616-21
81. Pitkin J, Rees M C, Gray S, et al. M anagement of premature menopause. Menopause Int 2007; 13: 44-5
82. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012; 19: 257-71
83. d e Villiers TJ, Gass ML, Haines CJ, et al. Global Consensus Statement on menopausal hormone therapy. Climacteric 2013; 16: 203-4
84. Panay N, Hamoda H, Arya R, Savvas M. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int 2013; 19: 59-68
85. Taboada M, Santen R, Lima J, et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with Turner syndrome. J Clin Endocrinol Metab 2011; 96: 3502-10
86. Torres-Santiago L, Mericq V, Taboada M, et al. Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): A randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metab 2013; 98: 2716-24
87. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005; 105: 944-52
88. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8
89. Wierman M E, Arlt W, Basson R, et al. Androgen therapy in women: A reappraisal: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3489-510
90. Davis SR, Worsley R. Androgen treatment of postmenopausal women. J Steroid Biochem Mol Biol 2014; 142: 107-14
91. Guerrieri G M, Martinez P E, Klug S P, et a l. E ffects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency. Menopause 2014; 21: 952-61
92. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-8
93. Cosman F, de Beur SJ, LeBoffMS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25: 2359-81
94. Reid D M, Doughty J, Eastell R, et al. G uidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group. Cancer Treatment Rev 2008; 34(Suppl 1): S3-18
95. C hallberg J, Ashcroft L, Lalloo F, et al. Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT. Br J Cancer 2011; 105: 22-7
96. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007; 14: 567-71
97. Mann E, Singer D, Pitkin J, Panay N, Hunter MS. Psychosocial adjustment in women with premature menopause: A crosssectional survey. Climacteric 2012; 15: 481-9
98. van der Stege JG, Groen H, van ZadelhoffS J, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008; 15: 23-31
99. The Daisy Network. h ttp://www.daisynetwork.org.uk/. Accessed January 5, 2015